|
|
|
||||||||||
Research Articles |
The purpose of this two-part review is to explain current drug treatment in part I and discuss investigational drug therapy and miscellaneous drugs in the management of parkinsonism in part II. The medical approach to this disease is still based on the imbalance between a deficiency of dopamine and a functional increase in acetylcholine. Anticholinergic agents are used to treat the tremors in the early stages of the disease.
This article has been cited by other articles:
![]() |
M. A. Wynalda and L. C. Wienkers Assessment of Potential Interactions Between Dopamine Receptor Agonists and Various Human Cytochrome P450 Enzymes Using a Simple In Vitro Inhibition Screen Drug Metab. Dispos., October 1, 1997; 25(10): 1211 - 1214. [Abstract] [Full Text] |
||||
![]() |
M. L. McPherson Management of Parkinson's disease Home Health Care Management Practice, January 1, 1992; 4(4): 31 - 35. [Abstract] [PDF] |
||||